AU7376494A - Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents - Google Patents

Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents

Info

Publication number
AU7376494A
AU7376494A AU73764/94A AU7376494A AU7376494A AU 7376494 A AU7376494 A AU 7376494A AU 73764/94 A AU73764/94 A AU 73764/94A AU 7376494 A AU7376494 A AU 7376494A AU 7376494 A AU7376494 A AU 7376494A
Authority
AU
Australia
Prior art keywords
treatment
combination
rheumatoid arthritis
inflammatory agents
thalidomide alone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73764/94A
Inventor
Peter J. Andrulis Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andrulis Pharmaceuticals Corp
Original Assignee
Andrulis Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrulis Pharmaceuticals Corp filed Critical Andrulis Pharmaceuticals Corp
Publication of AU7376494A publication Critical patent/AU7376494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
AU73764/94A 1993-08-04 1994-08-03 Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents Abandoned AU7376494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10172493A 1993-08-04 1993-08-04
US101724 1993-08-04
PCT/US1994/008742 WO1995004533A2 (en) 1993-08-04 1994-08-03 Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents

Publications (1)

Publication Number Publication Date
AU7376494A true AU7376494A (en) 1995-02-28

Family

ID=22286074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73764/94A Abandoned AU7376494A (en) 1993-08-04 1994-08-03 Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents

Country Status (2)

Country Link
AU (1) AU7376494A (en)
WO (1) WO1995004533A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143283B1 (en) 1993-03-01 2012-03-27 The Children's Medical Center Corporation Methods for treating blood-born tumors with thalidomide
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
US6228879B1 (en) 1997-10-16 2001-05-08 The Children's Medical Center Methods and compositions for inhibition of angiogenesis
US5629327A (en) 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
IT1276031B1 (en) * 1995-10-31 1997-10-24 Angelini Ricerche Spa PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTOIMMUNE DISEASES
CA2514681C (en) * 1996-11-05 2011-04-05 The Children's Medical Center Corporation Methods and compositions for inhibition of angiogenesis
US6673828B1 (en) 1998-05-11 2004-01-06 Children's Medical Center Corporation Analogs of 2-Phthalimidinoglutaric acid
DE10230381A1 (en) * 2002-07-05 2004-01-22 Institut für Medizintechnologie Magdeburg GmbH, IMTM Use of inhibitors of alanyl aminopeptidases and pharmaceutical compositions comprising them
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
PE20091836A1 (en) * 2008-04-21 2009-12-18 Otonomy Inc FORMULATIONS FOR THE EAR TO TREAT OTIC DISEASES AND CONDITIONS
EP2278999A4 (en) 2008-04-21 2015-04-22 Otonomy Inc Auris formulations for treating otic diseases and conditions
JP6076360B2 (en) 2011-10-18 2017-02-08 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク Medical device and method for collecting biological samples
CN106138052B (en) * 2015-04-16 2020-02-21 欣凯医药化工中间体（上海）有限公司 Thalidomide preparation and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues

Also Published As

Publication number Publication date
WO1995004533A3 (en) 1995-04-27
WO1995004533A2 (en) 1995-02-16

Similar Documents

Publication Publication Date Title
AU5233493A (en) Improving the biocompatibility of solid surfaces
AU6201194A (en) Container and its application
AU7376494A (en) Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
GB2282202B (en) Half nut capable of engaging resiliently another half nut
AU6946594A (en) Methods for the treatment and prevention of diarrhea
IL108375A0 (en) Treatment of waste petroleum
GB2281830B (en) I/q-modulator and i/q-demodulator
GB9420215D0 (en) Control of torsional stiffness in beams and the like
HU9502863D0 (en) 7-azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
AU8131694A (en) Treatment for rheumatoid arthritis
AU6392994A (en) Use of bicarbonates in the biodegradation of hydrocarbon contaminants
AU6098994A (en) Methods and agents for the diagnosis and treatment of rheumatoid arthritis
HU9402538D0 (en) Pharmaceutical composition and optical isomerization inhibitor
AU7847594A (en) Liquefaction of plastic materials
GB9303919D0 (en) Hinge arrangements their construction and use
AU1292995A (en) Bis-oxazolidine compounds and their use
GB9415309D0 (en) Desks and the like
AU7078094A (en) Allatostatins and their use
GB9305467D0 (en) Substituted cephalosporin sulfones useful in the treatment of cancer
AU8093894A (en) Photocatalytic destruction of contaminants in solids
AU6510394A (en) Polymorphisms in human phosphoglucomutase-1
GB9306456D0 (en) Composition and use
AU6149594A (en) Treatment of autoimmune and inflammatory disorders
AUPO103096A0 (en) Method of and composition for the treatment of rheumatoid arthritis and psoriatic arthritis